Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Baird Medical Investment Holdings (BDMDW) Accounts Payables (2023 - 2025)

Baird Medical Investment Holdings' quarterly Accounts Payables came in at $1.8 million in Q4 2025, up 44.1% year-on-year from $1.3 million in Q4 2024, and up 44.1% quarter-over-quarter from $1.3 million in Q4 2024.

Baird Medical Investment Holdings has reported Accounts Payables for 3 years, with the latest figure at $1.8 million in Q4 2025.

  • For the quarter ending Q4 2025, Accounts Payables rose 44.1% year-over-year to $1.8 million; the trailing twelve-month figure through Dec 2025 stood at $1.8 million (up 44.1% YoY), and the FY2025 full-year result was $1.8 million, up 44.1% from the prior year.
  • Accounts Payables for Q4 2025 stood at $1.8 million, up from $1.3 million in the prior quarter.
  • The five-year high for Accounts Payables was $1.8 million in Q4 2025, with the low at $550188.0 in Q4 2023.
  • Average Accounts Payables over 3 years is $1.2 million, with a median of $1.3 million recorded in 2024.
  • Year-over-year, Accounts Payables jumped 127.68% in 2024 and soared 44.1% in 2025.
  • Tracing BDMDW's Accounts Payables over 3 years: stood at $550188.0 in 2023, then jumped by 127.68% to $1.3 million in 2024, then surged by 44.1% to $1.8 million in 2025.
  • The last three Accounts Payables figures came in at $1.8 million (Q4 2025), $1.3 million (Q4 2024), and $550188.0 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 4.68 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.59 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 2.57 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.14 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 181.10 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2.33 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 2.07 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 3.41 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 338.80 Mn
10 Baird Medical Investment Holdings - - - 1.81 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1.81 Mn
Dec 31, 2024 1.25 Mn
Dec 31, 2023 550,188.00